China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) YoY EPS Growth : -11.76% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. China Resources Boya Bio-pharmaceutical Group Co's YoY EPS Growth for the quarter that ended in Mar. 2024 was -11.76%.

China Resources Boya Bio-pharmaceutical Group Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.30.

China Resources Boya Bio-pharmaceutical Group Co YoY EPS Growth Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co YoY EPS Growth Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

-9.91

-39.00

29.51

8.86

-45.35

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															61.90	-8.82	-3.57	-1,600.00	-11.76

China Resources Boya Bio-pharmaceutical Group Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

China Resources Boya Bio-pharmaceutical Group Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(0.47	-	0.86)	/	\| 0.86 \|
=	-45.35 %

China Resources Boya Bio-pharmaceutical Group Co's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(0.3	-	0.34)	/	\| 0.34 \|
=	-11.76 %

China Resources Boya Bio-pharmaceutical Group Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000

Website

https://www.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Headlines

No Headlines